GC31663
Lorecivivint
Also listed as Adavivint (SM04690)
Adavivint (SM04690) (SM04690; Lorecivivint) is a potent and selective inhibitor of canonical Wnt signaling, with an EC50 of 19·5 nM via a high-throughput TCF/LEF-reporter assay in SW480 colon cancer cells
ChemicalCAS1467093-03-3MW505.55FormulaC29H24FN7O
- CAS number
- 1467093-03-3
- Molecular weight
- 505.55
- Formula
- C29H24FN7O
- Solubility
- DMSO ： 25 mg/mL (49·45 mM)
- InChIKey
- AQDWDWAYVBQMAM-UHFFFAOYSA-N
- Catalogue number
- GC31663
- Brand
- GLPBIO
Computed properties PubChem CID 135565709 · XLogP 4.5 · TPSA 112 Ų · H-bond donors 3
- XLogP
- 4.5
- TPSA
- 112 Ų
- H-bond donors
- 3
- H-bond acceptors
- 6
- Rotatable bonds
- 6
- Heavy atoms
- 38
SMILES CC(C)CC(=O)NC1=CN=CC(=C1)C2=CC3=C(C=C2)NN=C3C4=NC5=C(N4)C=NC=C5C6=CC(=CC=C6)F
Computed descriptors from PubChem (CID 135565709), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il